Takeda Austria is a finished-dose manufacturer based in Austria. It holds one valid CEP. Its filings concentrate with EMA, RAMA (GE) and ARCSA (EC). Its GMP standing is certified by ANVISA (Brazil), MFDS (Korea) and EMA, among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 11 September 2025 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Linz, United Arab Emirates | Not on file |
| LINZ, Austria | Not on file |
| Austria, Austria | 3001157285 |
| Oberösterreich, Austria | Not on file |
| Oberoesterreich, Austria | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Deproteinised Hemoderivative Of Calf Blood | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | 10 | 2 |
| RAMA (GE) | 3 | None |
| ARCSA (EC) | 1 | None |
| INVIMA (CO) | 1 | None |
| MINSA (CR) | 1 | None |
| ANVISA (Brazil) | None | 3 |
| MFDS (Korea) | None | 2 |
| EAEU_EEC | None | 1 |
| US FDA | None | 1 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Takeda Austria comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.